199 related articles for article (PubMed ID: 17053955)
1. Fluoxetine for the treatment of fatigue in primary biliary cirrhosis: a randomized, double-blind controlled trial.
Talwalkar JA; Donlinger JJ; Gossard AA; Keach JC; Jorgensen RA; Petz JC; Lindor KD
Dig Dis Sci; 2006 Nov; 51(11):1985-91. PubMed ID: 17053955
[TBL] [Abstract][Full Text] [Related]
2. A Randomized, Placebo-Controlled Clinical Trial of Efficacy and Safety: Modafinil in the Treatment of Fatigue in Patients With Primary Biliary Cirrhosis.
Silveira MG; Gossard AA; Stahler AC; Jorgensen RA; Petz JL; Ali AH; Lindor KD
Am J Ther; 2017; 24(2):e167-e176. PubMed ID: 27148676
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, randomized, controlled trial of fluoxetine plus quetiapine or clomipramine versus fluoxetine plus placebo for obsessive-compulsive disorder.
Diniz JB; Shavitt RG; Fossaluza V; Koran L; Pereira CA; Miguel EC
J Clin Psychopharmacol; 2011 Dec; 31(6):763-8. PubMed ID: 22020357
[TBL] [Abstract][Full Text] [Related]
4. Oral antioxidant supplementation for fatigue associated with primary biliary cirrhosis: results of a multicentre, randomized, placebo-controlled, cross-over trial.
Prince MI; Mitchison HC; Ashley D; Burke DA; Edwards N; Bramble MG; James OF; Jones DE
Aliment Pharmacol Ther; 2003 Jan; 17(1):137-43. PubMed ID: 12492743
[TBL] [Abstract][Full Text] [Related]
5. A randomized, controlled crossover trial of ondansetron in patients with primary biliary cirrhosis and fatigue.
Theal JJ; Toosi MN; Girlan L; Heslegrave RJ; Huet PM; Burak KW; Swain M; Tomlinson GA; Heathcote EJ
Hepatology; 2005 Jun; 41(6):1305-12. PubMed ID: 15915460
[TBL] [Abstract][Full Text] [Related]
6. Effects of Fluoxetine on Outcomes at 12 Months After Acute Stroke: Results From EFFECTS, a Randomized Controlled Trial.
Lundström E; Isaksson E; Greilert Norin N; Näsman P; Wester P; Mårtensson B; Norrving B; Wallén H; Borg J; Hankey GJ; Hackett ML; Mead GE; Dennis MS; Sunnerhagen KS
Stroke; 2021 Oct; 52(10):3082-3087. PubMed ID: 34465201
[TBL] [Abstract][Full Text] [Related]
7. Fluoxetine versus placebo in posttraumatic stress disorder.
Martenyi F; Brown EB; Zhang H; Prakash A; Koke SC
J Clin Psychiatry; 2002 Mar; 63(3):199-206. PubMed ID: 11926718
[TBL] [Abstract][Full Text] [Related]
8. Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study.
Appelberg BG; Syvälahti EK; Koskinen TE; Mehtonen OP; Muhonen TT; Naukkarinen HH
J Clin Psychiatry; 2001 Jun; 62(6):448-52. PubMed ID: 11465522
[TBL] [Abstract][Full Text] [Related]
9. Rituximab Is Ineffective for Treatment of Fatigue in Primary Biliary Cholangitis: A Phase 2 Randomized Controlled Trial.
Khanna A; Jopson L; Howel D; Bryant A; Blamire A; Newton JL; Jones DE
Hepatology; 2019 Nov; 70(5):1646-1657. PubMed ID: 29790196
[TBL] [Abstract][Full Text] [Related]
10. Fluoxetine in social phobia: a double-blind, placebo-controlled pilot study.
Kobak KA; Greist JH; Jefferson JW; Katzelnick DJ
J Clin Psychopharmacol; 2002 Jun; 22(3):257-62. PubMed ID: 12006895
[TBL] [Abstract][Full Text] [Related]
11. Fluoxetine is not effective in the treatment of post-stroke fatigue: a double-blind, placebo-controlled study.
Choi-Kwon S; Choi J; Kwon SU; Kang DW; Kim JS
Cerebrovasc Dis; 2007; 23(2-3):103-8. PubMed ID: 17124389
[TBL] [Abstract][Full Text] [Related]
12. Fluoxetine in pathologic skin-picking: open-label and double-blind results.
Bloch MR; Elliott M; Thompson H; Koran LM
Psychosomatics; 2001; 42(4):314-9. PubMed ID: 11496020
[TBL] [Abstract][Full Text] [Related]
13. Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial.
Geller DA; Hoog SL; Heiligenstein JH; Ricardi RK; Tamura R; Kluszynski S; Jacobson JG;
J Am Acad Child Adolesc Psychiatry; 2001 Jul; 40(7):773-9. PubMed ID: 11437015
[TBL] [Abstract][Full Text] [Related]
14. A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA.
Schattenberg JM; Pares A; Kowdley KV; Heneghan MA; Caldwell S; Pratt D; Bonder A; Hirschfield GM; Levy C; Vierling J; Jones D; Tailleux A; Staels B; Megnien S; Hanf R; Magrez D; Birman P; Luketic V
J Hepatol; 2021 Jun; 74(6):1344-1354. PubMed ID: 33484775
[TBL] [Abstract][Full Text] [Related]
15. RITPBC: B-cell depleting therapy (rituximab) as a treatment for fatigue in primary biliary cirrhosis: study protocol for a randomised controlled trial.
Jopson L; Newton JL; Palmer J; Floudas A; Isaacs J; Qian J; Wilkinson J; Trenell M; Blamire A; Howel D; Jones DE
BMJ Open; 2015 Aug; 5(8):e007985. PubMed ID: 26297361
[TBL] [Abstract][Full Text] [Related]
16. A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia.
Arnold LM; Hess EV; Hudson JI; Welge JA; Berno SE; Keck PE
Am J Med; 2002 Feb; 112(3):191-7. PubMed ID: 11893345
[TBL] [Abstract][Full Text] [Related]
17. The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: a double blind, randomized, placebo-controlled study.
Kuiken SD; Tytgat GN; Boeckxstaens GE
Clin Gastroenterol Hepatol; 2003 May; 1(3):219-28. PubMed ID: 15017494
[TBL] [Abstract][Full Text] [Related]
18. The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder.
Lam RW; Levitt AJ; Levitan RD; Enns MW; Morehouse R; Michalak EE; Tam EM
Am J Psychiatry; 2006 May; 163(5):805-12. PubMed ID: 16648320
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial.
AFFINITY Trial Collaboration
Lancet Neurol; 2020 Aug; 19(8):651-660. PubMed ID: 32702334
[TBL] [Abstract][Full Text] [Related]
20. A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients.
Sechter D; Troy S; Paternetti S; Boyer P
Eur Psychiatry; 1999 Mar; 14(1):41-8. PubMed ID: 10572324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
